Get started
Work

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Year: 2008
Type: article
DOI: 10.1007/s00198-008-0670-7
Authors: J. Compston, D. M. Reid, J. Boisdron, M.-L. Brandi, N. Burlet, D. Cahall, P. D. Delmas, W. Dere, J.-P. Devogelaer, L. A. Fitzpatrick, B. Flamion, N. Goel, S. Korte, A. Laslop, B. Mitlak, S. Ormarsdottir, J. Ringe, R. Rizzoli, Y. Tsouderos, T. Van Staa, J.-Y. Reginster
Institutions: University of Cambridge, University of Aberdeen, F. Hoffmann-La Roche AG, University of Florence, International Osteoporosis Foundation, Sanofi (France), Inserm, Amgen (United States), UCLouvain, GlaxoSmithKline (United States), University of Namur, UCB Pharma (United States), Novartis (Switzerland), Austrian Agency for Health and Food Safety, Eli Lilly (United States), University of Cologne, Klinikum Leverkusen, University of Geneva, World Health Organization, University Hospital of Geneva, Servier (France), Institut de Recherches Internationales Servier (France), Medicines and Healthcare products Regulatory Agency, University of Liège
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2016106557
FWCI: 3.436
Cites: 23
Cited by: 31
Related to: 10